Hening Liu

机构：China Pharmaceutical University · ORCID：0000-0002-4982-9595

发表论文 64 篇 · 总被引 1496 次 · h-index 23

代表论文

• Extracellular Vesicles‐Derived Hybrid Nanoplatforms for Amplified CD47 Blockade‐Based Cancer Immunotherapy (2023 · Advanced Materials · 被引 164)
• Blood–Brain Barrier‐Penetrating and Lesion‐Targeting Nanoplatforms Inspired by the Pathophysiological Features for Synergistic Ischemic Stroke Therapy (2024 · Advanced Materials · 被引 114)
• Combination of Nanomaterials in Cell-Based Drug Delivery Systems for Cancer Treatment (2021 · Pharmaceutics · 被引 95)
• Dual-targeting nanozyme combined with aPD-L1-based immunotherapy for combating cancer recurrence and metastasis (2024 · Materials Today · 被引 56)
• Black Phosphorus Quantum Dot Loaded Bioinspired Nanoplatform Synergized with aPD-L1 for Multimode Cancer Immunotherapy (2024 · Nano Letters · 被引 55)
• Chemoimmunotherapeutic Nanogel for Pre- and Postsurgical Treatment of Malignant Melanoma by Reprogramming Tumor-Associated Macrophages (2024 · Nano Letters · 被引 50)